To further investigate the role of MAT1A in tumor relapse following gemcitabine treatment, we overexpressed MAT1A in transient transfections of 5637 cells (5637MAT1A+) (Figure 4C) and compared the gemcitabine IC50 profile of these cells to mock transfected controls. The gene discussed is MAT1A; the disease is neoplasm.